Psychiatry and Behavioral Sciences

Keyphrases

1. Schizophrenia 100%
2. Major Depressive Disorder 61%
3. Schizophrenic Patients 45%
4. Antipsychotics 41%
5. Clozapine 40%
6. Alzheimer's Disease 38%
7. Depressive Symptoms 34%
8. Older Adults 32%
9. Bipolar Disorder 27%
10. Primary Progressive Aphasia 26%
11. Atypical Antipsychotics 26%
12. United States 26%
13. Hippocampus 23%
14. Psychopathology 22%
15. Randomized Controlled Trial 20%
16. Patients with Schizophrenia 20%
17. Caregivers 19%
18. Cognitive Behavioral Therapy 19%
19. Antidepressants 19%
20. Placebo 18%
21. Quality of Life 18%
22. Anxiety Disorders 18%
23. Pediatric 17%
24. Mental Health 17%
25. Nucleus Accumbens 17%
26. Risk Factors 16%
27. Meta-analysis 16%
28. Transgender 16%
29. Primary Care 16%
30. Functional Magnetic Resonance Imaging 16%
31. Confidence Interval 16%
32. Attention Deficit Hyperactivity Disorder 15%
33. Haloperidol 15%
34. Psychiatric Disorders 15%
35. Healthy Controls 15%
36. Cognitive Impairment 14%
37. Substance Use 14%
38. Psychosis 14%
39. Amygdala 14%
40. Suicide 14%
41. Obsessive-compulsive Disorder 14%
42. Alcohol 13%
43. Substance Use Disorder 13%
44. Eating Disorders 13%
45. Medial Prefrontal Cortex (mPFC) 13%
46. Dopamine 13%
47. Treatment Response 12%
48. Phencyclidine 12%
49. Executive Function 12%
50. Illness 12%
51. Selective Serotonin Reuptake Inhibitors 12%
52. Tourette Syndrome 12%
53. Chicago 12%
54. Autism Spectrum Disorder 12%
55. Postpartum Depression 12%
56. Parent Report 11%
57. Olanzapine 11%
58. Depressed Patients 11%
59. Posttraumatic Stress Disorder 11%
60. Tardive Dyskinesia 11%
61. Negative Symptoms 11%
62. Health-related Quality of Life 11%
63. Cognitive Function 11%
64. Dementia 11%
65. During Pregnancy 11%
66. Fluoxetine 11%
67. Risperidone 11%
68. Suicidal Ideation 10%
69. Type 1 Diabetes Mellitus (T1DM) 10%
70. 5-hydroxytryptamine 10%
71. Preventive Intervention 10%
72. AIDS/HIV 10%
73. Young children 10%
74. Treatment Outcome 10%
75. Brain Regions 10%
76. Schizophrenia Symptoms 10%
77. Pregnant Women 10%
78. Alcohol Use 10%
79. Anxiety Symptoms 10%
80. COVID-19 Pandemic 10%
81. Diabetes 10%
82. Clinical Trials 10%
83. Frontotemporal Dementia 9%
84. Alzheimer's Dementia 9%
85. Dopamine Release 9%
86. Control Subjects 9%
87. Mood Disorders 9%
88. High Risk 9%
89. Comorbidity 9%
90. Odds Ratio 9%
91. Working Memory 9%
92. Comorbid 9%
93. Psychotherapy 9%
94. Randomized Trial 9%
95. Serotonin 9%
96. Drug Use 9%
97. African American 9%
98. Antipsychotic-induced Weight Gain 9%
99. Type I Diabetes 9%
100. Neuropsychological Tests 9%